Avemar Research
Avemar is recognized as the world’s first fermented wheat germ extract (FWGE) product, developed using a patented and proprietary process. Its meticulously refined fermentation method enriches Avemar with specific bioactive molecules, which contribute to its groundbreaking biological effects. Avemar has been proven to:
- Support Mitochondrial Rescue
- Reduce the Warburg Effect
- Support the Immune System, Quality of Life, Mental Clarity, Memory, Brain and Organ Health
- Support Renewed Vitality, Stamina and Enhanced Energy
- Support Metabolic Regulation
Introduced in 1998 by Dr. Máté Hidvégi, Avemar’s formulation is based on the research of Nobel laureate Albert Szent-Györgyi and is produced exclusively in Hungary under strict pharmaceutical manufacturing conditions at the FDA approved, GMP certified plant of Biropharma.
Since its inception, Avemar has been the subject of over 50 international clinical studies, including numerous peer-reviewed publications and clinical trials that have evaluated its efficacy and safety across various indications.
It is critical to note that some companies have been using Avemar’s own clinical research data and results to promote other, fundamentally different products. The composition, manufacturing process, and quality of all fermented wheat germ extract products vary significantly. Only Avemar has undergone extensive international testing and validation; therefore, clinical results obtained with Avemar absolutely cannot be extrapolated to any other fermented wheat germ extract products.
Dr. Hidvégi, Avemar’s inventor, has recently published a comprehensive video detailing the mechanisms of action and immunological effects of Avemar, which is accessible on YouTube.
For independent research information about Avemar, the following resources are recommended:
Extensive high-level clinical research in the United States has validated the efficacy of Avemar and sought to identify the specific molecular components responsible for its unique therapeutic benefits. Notably:
-
Dr. Máté Hidvégi, the inventor of Avemar, collaborated with Nobel laureate James D. Watson and colleagues at Cold Spring Harbor Laboratory to investigate Avemar’s mechanisms of action. Their research demonstrated that Avemar suppresses the Warburg effect, restores oxidative mitochondrial function, and inhibits tumor growth in vivo. A distinct fraction within Avemar, designated as 'A250', was identified as being responsible for these effects. Due to the extraction method, A250 is not available as a standalone product, but is 100% present within the orginal Avemar formulation.
-
At the University of California, Davies, Professor John Tuscano isolated specific protein fractions from Avemar and demonstrated their valuable immunomodulatory properties. These beneficial proteins are available when Avemar is consumed.
For downloadable PDF studies and comprehensive research, please visit the official Avemar Research website.
